Abstract
4,4′-Dimethylaminorex is a stimulant novel psychoactive substance (NPS) first detected in Europe in November 2012. It is a derivative of 4-methylaminorex, a substance controlled under Schedule 1 of the 1971 United Nations Convention on Psychotropic Substances. There is currently no information on the availability or cost of these substances from Internet suppliers. An Internet snapshot study was undertaken in English using established European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) methodology to determine the availability of 4-methylaminorex and 4,4′-dimethylaminorex in April 2014. Twenty Internet sites selling 4-methylaminorex were identified, 18 selling in US dollars and two in GB Pound Sterling. Fourteen (70 %) Internet sites had a minimum purchase amount of ≥10 g (compared to user doses of 10–25 mg). For the 18 suppliers selling in US$, 9 quoted a fixed price per gram irrespective of the amount ordered and 11 had a reducing price per gram with increasing purchase quantity (US$30.8 ± 34.2/g for 1 g purchase to US$15.2 ± 20.3/g for 1 kg purchase). Only one Internet site selling 4,4′-dimethylaminorex was identified, selling in Euros. The minimum purchase quantity was 500 mg. The price per gram reduced from €36.08/g for a 500 mg purchase to €2.20/g for a 100 g purchase. This Internet snapshot demonstrated that there was a greater availability from Internet suppliers of products advertised as 4-methylaminorex than 4,4′-dimethylaminorex, despite the 4-methylaminorex being an internationally controlled substance. Whilst this may reflect misunderstanding by suppliers, it has the potential to put those purchasing at risk of contravening border control and/or local law enforcement legislation. The use of methodology such as Internet snapshot surveys is of increasing interest to clinical/medical toxicologists in their understanding of the supply, availability and cost of novel psychoactive substances.
Similar content being viewed by others
References
Wood DM, Dargan PI (2012) Novel psychoactive substances: how to understand the toxicity (harm) associated with the use of these substances. Ther Drug Monit 34:363–367
Wood DM, Dargan PI (2012) Use and acute toxicity associated with the novel psychoactive substances diphenolprolinol (D2PM) and desoxypipradrol (2-DPMP). Clin Toxicol (Phila) 50:727–732
Dargan PI, Wood DM (2011) Novel and emerging recreational drugs: routes of supply and the role of the Internet. Clin Toxicol (Phila) 49:199–200
Wood DM, Dargan PI (2012) Understanding how data triangulation identifies acute toxicity of novel psychoactive drugs. J Med Toxicol 8:300–303
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). European drug report: trends and developments. 2012. http://www.emcdda.europa.eu/attachments.cfm/att_190854_EN_TDAC12001ENC_pdf. Accessed 17 June 2014
Wood DM, Davies S, Puchnaewicz M, Button J, Archer R, Ovaska H, Ramsey J, Lee T, Holt DW, Dargan PI (2010) Recreational use of Mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity. J Med Toxicol 6:327–330
Gibbons S (2012) ‘Legal highs’—novel and emerging psychoactive drugs: a chemical overview for the toxicologist. Clin Toxicol (Phila) 50:15–24
EMCDDA-Europol Joint Report on a new psychoactive substance: 4,4’-DMAR (4-methyl-5-(-4-methylphenyl)-4,5-dihydrooxazol-2-amine)
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Briefing paper: online sales of new psychoactive substances/‘legal highs’: summary of results from the 2011 multilingual snapshots. 2011. http://www.emcdda.europa.eu/attachements.cfm/att.143801_EN_SnapshotSummary.pdf. Accessed 17 June 2014
Hillebrand J, Olszewski D, Sedefov R (2010) Legal highs on the Internet. Subst Use Misuse 45:330–340
Wood DM, Dargan PI (2014) Using Internet snapshot surveys to enhance our understanding of the availability of the novel psychoactive substance alpha-methyltryptamine (AMT). Subst Use Misuse 49:7–12
Vermette-Marcotte A-E, Dargan PI, Archer JRH, Gosselin S, Wood DM. (2014) An Internet snapshot study to compare the international availability of the novel psychoactive substance methiopropamine. Clin Toxicol (Phila) 52:678–681
Erowid. 4-Methylaminorex. https://www.erowid.org/chemicals/4_methylaminorex/4_methylaminorex.shtml. Accessed 17 June 2014
Drugs Forum. Dimethylaminorex, 4-DMAR, Direx. http://www.drugs-forum.com/forum/showthread.php?t=83865. Access 17 June 2014
Ramsey J, Dargan PI, Smyllie M, Davies S, Button J, Holt DW, Wood DM (2010) Buying “legal” recreational drugs does not mean that you aren’t breaking the law. Q J Med 103:777–783
Davies S, Wood DM, Smith G, Button J, Ramsey J, Archer R, Holt DW, Dargan PI (2010) Purchasing ‘legal highs’ on the Internet—is there consistency in what you get? Q J Med 103:489–493
Brandt SD, Freeman S, Sumnall HR, Measham F, Cole J (2011) Analysis of NRG ‘legal highs’ in the UK: identification and formation of novel cathinones. Drug Test Anal 3:569–575
Brandt SD, Sumnall HR, Measham F, Cole J (2010) Analyses of second-generation ‘legal highs’ in the UK: initial findings. Drug Test Anal 2:377–382
Brandt SD, Sumnall HR, Measham F, Cole J (2010) Second generation mephedrone. The confusing case of NRG-1. BMJ 341:c3564
Spiller HA, Ryan ML, Weston RG, Jansen J (2011) Clinical experience with and analytical confirmation of “bath salts” and “legal highs” (synthetic cathinones) in the United States. Clin Toxicol (Phila) 49:499–505
Conflict of Interest
The authors report no conflicts of interest in relation to this study.
Funding
There was no specific funding in relation to this study
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nizar, H., Dargan, P.I. & Wood, D.M. Using Internet Snapshot Surveys to Enhance Our Understanding of the Availability of the Novel Psychoactive Substance 4-Methylaminorex and 4,4′-Dimethylaminorex. J. Med. Toxicol. 11, 80–84 (2015). https://doi.org/10.1007/s13181-014-0425-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13181-014-0425-0